FDA Import Refusal AEK-7655631-3/10003/1 — Novo Nordisk Pharmaceutical
The FDA refused shipment AEK-7655631-3/10003/1 from Novo Nordisk Pharmaceutical (Brazil) on Sep 29, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 29, 2025
- Country
- Brazil
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,75